
Pinion Immunotherapeutics is a biotechnology company that leverages AI and structural biology for advanced mRNA antigen design and an innovative LNP formulation. Their approach aims to harness the body’s natural immune response, stimulating T-cells and antibodies to achieve functional cures for chronic viral infections and cancer. They are developing immunotherapies targeting persistent viral infections like HPV, HBV, EBV, and HSV, with a goal to provide functional cures and improve patient outcomes. Their lead program focuses on HPV, aiming to replace current treatments like LEEP with a safe and effective mRNA immunization.

Pinion Immunotherapeutics is a biotechnology company that leverages AI and structural biology for advanced mRNA antigen design and an innovative LNP formulation. Their approach aims to harness the body’s natural immune response, stimulating T-cells and antibodies to achieve functional cures for chronic viral infections and cancer. They are developing immunotherapies targeting persistent viral infections like HPV, HBV, EBV, and HSV, with a goal to provide functional cures and improve patient outcomes. Their lead program focuses on HPV, aiming to replace current treatments like LEEP with a safe and effective mRNA immunization.